AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2025
Jun 26, 2025
32559_dirs_2025-06-25_7f8bb3fe-e946-4569-a7db-85c046ab6461.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2025-06-25
Reporting Person: Burroughs Amy L. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-25 | Common Stock | P | 23314.00 | $3.8702 | Acquired | 47083.00 | Direct |
Footnotes
F1: Includes 4,160 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on May 31, 2025.